Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules

Appendix (Figure 9). Test selection is shown to be a function of pretest probability and the corresponding post-test probability once the results of CT are known. Recommendations are similar regardless of whether societal willingness to pay is $50 000 or $100 000 per quality-adjusted life-year ( ) gained. Note that surgery is preferred when positron emission tomography ( ) results are positive, biopsy is preferred when PET results are negative, and watchful waiting is preferred when biopsy results are nondiagnostic. FDG-PET = positron emission tomography with 18-fluorodeoxyglucose.
Appendix (Figure 9). Test selection is shown to be a function of pretest probability and the corresponding post-test probability once the results of CT are known. Recommendations are similar regardless of whether societal willingness to pay is $50 000 or $100 000 per quality-adjusted life-year ( ) gained. Note that surgery is preferred when positron emission tomography ( ) results are positive, biopsy is preferred when PET results are negative, and watchful waiting is preferred when biopsy results are nondiagnostic. FDG-PET = positron emission tomography with 18-fluorodeoxyglucose. Recommended sequence of diagnostic testing in patients who are at average risk for surgical complications, according to pretest probability, computed tomography (CT) results, and threshold that determines cost-effectiveness.QALYPET

This Article

  1. Ann Intern Med May 6, 2003 vol. 138 no. 9 724-735
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)
  5. Appendix Table 1

Current Issue

  1. December 1, 2009, 151 (11)
  1. Alert me to current issues